CHARGE study
CHARGE Study[edit | edit source]
The CHARGE Study (Cohorts for Heart and Aging Research in Genomic Epidemiology) is a collaborative research initiative aimed at understanding the genetic basis of cardiovascular and aging-related diseases. The study brings together multiple large cohort studies to perform genome-wide association studies (GWAS) and other genomic analyses.
Background[edit | edit source]
The CHARGE Study was established to address the need for large-scale genomic data to identify genetic variants associated with common diseases. It leverages the power of collaboration by combining data from several cohort studies, each with extensive phenotypic and genotypic information.
Participating Cohorts[edit | edit source]
The CHARGE Study includes several major cohort studies, such as:
- Framingham Heart Study
- Atherosclerosis Risk in Communities Study (ARIC)
- Cardiovascular Health Study (CHS)
- Rotterdam Study
- Age, Gene/Environment Susceptibility Study (AGES)
These cohorts provide a diverse population base, enhancing the study's ability to detect genetic associations across different populations.
Research Focus[edit | edit source]
The primary focus of the CHARGE Study is on cardiovascular diseases, but it also explores other aging-related conditions. Key areas of research include:
Methodology[edit | edit source]
The CHARGE Study employs genome-wide association studies (GWAS) to identify genetic variants linked to specific traits and diseases. It uses advanced statistical methods to analyze the large datasets generated by the participating cohorts.
Achievements[edit | edit source]
The CHARGE Study has contributed significantly to the understanding of the genetic basis of cardiovascular and aging-related diseases. It has identified numerous genetic loci associated with these conditions, providing insights into potential biological pathways and targets for therapeutic intervention.
Future Directions[edit | edit source]
The CHARGE Study continues to expand its research scope by incorporating new cohorts and exploring additional phenotypes. It aims to integrate multi-omics data, such as epigenomics and metabolomics, to gain a more comprehensive understanding of the genetic and environmental factors influencing health and disease.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
